Why the study?
Although COVID-19 is associated with cardiovascular complications, the true incidence of direct cardiac complications remains unclear, creating uncertainties for clinicians managing this novel disease.
This review highlights the uncertainties and lack of clarity regarding the true incidence of direct cardiac complications associated with COVID-19.
May signal vascular complications in COVID-19; leaves open mechanistic and therapeutic questions for prospective study.
Since the first description of COVID-19 in December 2019, more than 63,000 publications have described its virology, clinical course, management, treatment and prevention. Most physicians are now encountering, or will soon encounter, patients with COVID-19 and must attempt to simultaneously assimilate this avalanche of information while managing an entirely novel disease with few guiding precedents. It is increasingly clear that, although primarily a respiratory illness, COVID-19 is associated with cardiovascular complications. However, the true incidence of direct cardiac complications remains unclear, as all complications thus far reported can also occur in patients without COVID-19. In this review, we briefly summarise and critically appraise the data on cardiac complications associated with COVID-19 and describe some cases from our own experience. We identify unresolved questions and highlight the many uncertainties in this developing field.
No takes yet. Share an insight, caveat, or question.
Al‐Mohammad et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: